Ridgeback Biotherapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ridgeback Biotherapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • Ridgeback Biotherapeutics's estimated revenue per employee is $155,000

Employee Data

  • Ridgeback Biotherapeutics has 11 Employees.(i)
  • Ridgeback Biotherapeutics grew their employee count by -8% last year.

Ridgeback Biotherapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
SVP, Product DevelopmentReveal Email/Phone
3
SVP, Product DevelopmentReveal Email/Phone
4
Director, Clinical OperationsReveal Email/Phone
5
Associate Director Clinical Operations at Ridgeback BiotherapeuticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is Ridgeback Biotherapeutics?

Ridgeback Biotherapeutics is a biotechnology company focused on developing treatments and diagnostics for underserved patient populations primarily in pediatric orphan and emerging infectious diseases. The team at Ridgeback is dedicated to working toward finding life-saving and life changing solutions for patients and diseases that need champions. Headquartered in Miami, Florida, Ridgeback Biotherapeutics is a privately held, majority woman-owned biotechnology company; all funding for Ridgeback Biotherapeutics has originated from Wayne and Wendy Holman; two science driven individuals who invest in technologies that they believe will make the world a better place.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M11-21%N/A
#2
$1M110%N/A
#3
$1M1110%N/A
#4
$0.4M1122%$2.3M
#5
$1M11N/AN/A